Cogitat secures a £500k Innovate UK grant to advance brain computer interface technology for stroke recovery
The Imperial College spinout received the funding in partnership with Unit9 to prepare for NHS trials.
Cogitat is a London based medical technology spinout that builds non-invasive brain computer interfaces. The company uses artificial intelligence to decode neural signals from wearable headsets.
Cogitat, an Imperial College London spinout developing non-invasive brain computer interfaces, has secured a £500k grant from Innovate UK. The funding will be delivered in partnership with games developer Unit9 to support clinical trials with NHS stroke patients.
The capital will be directed towards advancing the company's research and development programme. Specifically, Cogitat will build its brain decoding software for integration into Unit9's virtual reality telerehabilitation platform ahead of trials scheduled for early 2024.
Founded in 2020, Cogitat uses artificial intelligence to translate motor cortex signals from wearable headsets into computer software inputs. The technology aims to improve recovery outcomes by increasing patient engagement during stroke rehabilitation exercises.
From the founder
"Innovate UK's grant is vital to the next stage of our development as we believe our neurotechnology can be a valuable tool for the under-resourced stroke rehabilitation market. We have developed a way to decode brainwaves from the motor cortex with a wearable headset that links with virtual reality games to increase patient engagement and encourage the repetitive limb movements required for rehabilitation."
Allan Ponniah
Founder at Cogitat
Use of funds
- 01Fund research and development
